Heartflow (HTFL) Gains from Investment Securities (2024 - 2025)
Heartflow's quarterly Gains from Investment Securities came in at $41.2 million in Q4 2025, up 150.21% year-on-year from $16.5 million in Q4 2024, and up 28.4% quarter-over-quarter from $32.1 million in Q3 2025.
Heartflow has reported Gains from Investment Securities for 2 years, with the latest figure at $41.2 million in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities rose 150.21% year-over-year to $41.2 million; the trailing twelve-month figure through Dec 2025 stood at $90.6 million (changed N/A YoY), and the FY2025 full-year result was $469508.0, down 94.5% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at $41.2 million, up from $32.1 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $41.2 million in Q4 2025, with the low at $585000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.22 Mn |
| Dec 31, 2025 | 41.22 Mn |
| Sep 30, 2025 | 32.10 Mn |
| Sep 30, 2025 | 32.10 Mn |
| Jun 30, 2025 | 863,000.00 |
| Jun 30, 2025 | 863,000.00 |
| Dec 31, 2024 | 16.47 Mn |
| Dec 31, 2024 | 16.47 Mn |
| Sep 30, 2024 | 585,000.00 |
| Sep 30, 2024 | 585,000.00 |
| Jun 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 3.91 Mn |